Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Norleucine phosphonate is a synthetic small molecule analog of the amino acid norleucine, in which the carboxylic acid group is replaced by a phosphonic acid moiety. Its chemical formula is C5H14NO3P and it has a molecular weight of 167.14 g/mol[1][2][7]. Norleucine itself is an isomer of leucine and has been used as a probe in biochemical studies, but norleucine phosphonate represents a distinct compound with altered physicochemical properties due to the presence of the phosphonate group[6][7]. Norleucine phosphonates are generally considered as mimics or inhibitors in enzymology, particularly for enzymes that act on amino acids or peptides; however, there are no approved medical indications or clinical uses for this compound at present[1]. It remains an experimental molecule with no known mechanism of action established in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on norleucine phosphonate.